Document is current
Any future updates will be listed below
-
Authors
Ahn, Sang Min https://orcid.org/0000-0003-0641-4493
Lee, Yongseop https://orcid.org/0000-0002-0116-6710
Heo, Seok-Jae
Yun, I Ji https://orcid.org/0009-0009-4773-2165
Park, Hyo Won https://orcid.org/0009-0003-0584-7331
Park, Yoon Soo https://orcid.org/0000-0003-4640-9525
Kim, Dong-Sook https://orcid.org/0000-0003-2372-1807
Kim, Yong Chan https://orcid.org/0000-0001-5081-7906
-
Funding
Funding for this research was provided by:
Korea Disease Control and Prevention Agency (2023-10-010)
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 18 January 2026
First Online: 1 April 2026
Declarations
:
: The Institutional Review Board of the Yonsei University Health System Clinical Trial Center approved this study and waived the requirement for informed consent (approval number 9-2023-0214). This study was conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
: Preliminary results of this study were presented as a poster presentation (P2AS-010) at the 14th International Symposium on Antimicrobial Agents and Resistance & 2024 Annual Conference of the Korean Society for Antimicrobial Therapy (ISAAR 2024 & KSAT).
: Not applicable.
